Treatment of malignant carcinoid tumors: a randomized controlled study of streptozocin plus 5-FU and human leukocyte interferon
- 31 October 1989
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 25 (10), 1475-1479
- https://doi.org/10.1016/0277-5379(89)90107-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cytotoxic Treatment in Patients with Malignant Carcinoid Tumors: Response to streptozocin—alone or in combination with 5-FUActa Oncologica, 1987
- Treatment of the Malignant Carcinoid SyndromeThe New England Journal of Medicine, 1986
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaThe New England Journal of Medicine, 1986
- Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.Gut, 1985
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaThe New England Journal of Medicine, 1984
- Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid SyndromeThe New England Journal of Medicine, 1983
- Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphomaBlood, 1981
- Simple and rapid determination of 5-hydroxyindole-3-acetic acid in urine by direct injection on a liquid chromatographic columnClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Large-scale Production of Human Leukocyte Interferon Containing 108 Units per mlJournal of General Virology, 1978
- Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)Cancer, 1974